-
Apr 30, 2024 | 
lexology.com | Meghan E. Hill |Martin J. Mackowski |Christopher Gordon |Paul Erian
In a long-anticipated move that dramatically alters the employment landscape, the Federal Trade Commission (FTC) issued its final Non-Compete Clause Rule (final rule) effectively banning employee non-compete agreements throughout the US. After receiving over 26,000 public comments, the FTC determined that the use of non-compete agreements with workers constitutes an "unfair method of competition" in violation of Section 5 of the FTC Act.
-
Jan 22, 2024 | 
lexology.com | Martin J. Mackowski |Barry A. Pupkin |Christopher Gordon |Kaitlin Rittgers
As 2024 gets underway, the US Department of Justice (DOJ) and the Federal Trade Commission (FTC) (collectively, the “agencies”) are continuing to take an aggressive approach to antitrust enforcement. Here are the key antitrust compliance issues that should be on in-house counsel radars in the new year. 1.
-
Jan 18, 2024 | 
natlawreview.com | Eric A. Klein |Sara Helene Shanti |Barry A. Pupkin |Christopher Gordon
Skip to main content January 18, 2024 Volume XIV, Number 18 Legal Analysis. Expertly Written. Quickly Found. Trending News Romania | Work Permit Quota Set for 2024 Print Mail Download i The Romanian government has published its annual quota for workers from outside the European Union, European Economic Area and Switzerland.
-
Jan 9, 2024 | 
natlawreview.com | Christopher Gordon
In 2022, the state of California passed into law the California Health Care Quality and Affordability Act which requires that health care entities give the state 90-day notice of certain mergers, acquisitions, or other transactions projected to close on or after April 1, 2024. Review of these transactions began on January 1, 2024.
-
Jan 9, 2024 | 
lexology.com | Christopher Gordon |Kaitlin Rittgers
In 2022, the state of California passed into law the California Health Care Quality and Affordability Act which requires that health care entities give the state 90-day notice of certain mergers, acquisitions, or other transactions projected to close on or after April 1, 2024. Review of these transactions began on January 1, 2024.
-
Nov 16, 2023 | 
lexology.com | Christopher Gordon |D. Michael Kaye |Martin J. Mackowski |Gorka Navea |Michael Wray |Kaitlin Rittgers
We recently reported that the European Commission decided to end a rule exempting liner shipping services from certain EU antitrust rules, by letting the Consortia Block Exemption Regulation (CBER) expire on April 25, 2024. With the Biden administration’s stepped-up antitrust enforcement focus, the EU Commission decision raises an interesting question – what will Congress and the Federal Maritime Commission (FMC) do in response?
-
Sep 28, 2023 | 
mondaq.com | Christopher Gordon
On September 21, 2023, the Federal Trade Commission (FTC) filed
a lawsuit against U.S. Anesthesia Partners, Inc. (USAP) and private
equity firm Welsh, Carson, Anderson & Stowe, alleging that they
engaged in anticompetitive practices in the anesthesia services
market in Texas. According to the FTC's complaint, USAP and Welsh Carson executed a
multi-year strategy to consolidate anesthesiology practices in
Texas, raise the prices of anesthesia services, and increase their
own profits.
-
Sep 26, 2023 | 
natlawreview.com | Christopher Gordon
Skip to main contentSeptember 26, 2023Volume XIII, Number 269Legal Analysis. Expertly Written. Quickly Found. Trending NewsU.S. Federal Trade Commission Challenges Private Equity Firm’s Acquisition Spree in Texas PrintMailDownloadiOn September 21, 2023, the Federal Trade Commission (FTC) filed a lawsuit against U.S. Anesthesia Partners, Inc.
-
Sep 26, 2023 | 
lexology.com | Christopher Gordon
On September 21, 2023, the Federal Trade Commission (FTC) filed a lawsuit against U.S. Anesthesia Partners, Inc. (USAP) and private equity firm Welsh, Carson, Anderson & Stowe, alleging that they engaged in anticompetitive practices in the anesthesia services market in Texas. According to the FTC’s complaint, USAP and Welsh Carson executed a multi-year strategy to consolidate anesthesiology practices in Texas, raise the prices of anesthesia services, and increase their own profits.
-
Aug 24, 2023 | 
lexology.com | Kaitlin Rittgers |Christopher Gordon
This summer, the Federal Trade Commission (“FTC”) and U.S. Department of Justice (“DOJ”) (together “antitrust agencies” or “agencies”) continued to push boundaries on what constitutes anticompetitive conduct with the withdrawal of key healthcare policy statements and heightened scrutiny of the pharmaceutical industry. This summer also saw the DOJ and FTC score crucial enforcement wins in the form of two major healthcare settlements.
